Tag: Scott Gottlieb
FDA Issues Opioid Crisis Product Challenge
To mitigate the risk of addiction from prescribed opioid pain medication, the United States Food and Drug Administration (FDA) has called for the development...
FDA Moves to Better Control Loperamide Amid Opioid Crisis
The head of the United States Federal Drug Administration has announced that steps will be taken to better control loperamide, a drug which is...
FDA’s Gottlieb Speaks at Opioid Abuse Summit
The Commissioner of the United States Food and Drug Administration, Scott Gottlieb, spoke at the annual National Rx Drug Abuse and Heroin Summit on...
FDA Labels Opioid Cough Meds Unsafe for Kids
The FDA has determined that opioid cold and cough medicines should not be used for treating children under the age of 18.
According to a...
FDA’s Gottlieb Suggests Corporate-Sponsored Prescription Opioid Monitoring
The Commissioner of Food and Drugs, Scott Gottlieb, made remarks at a public workshop that suggested drug manufacturers and sellers might be required to...
Opioid Withdrawal Device Approved by FDA
The FDA has approved an opioid withdrawal device made by Innovative Health Solutions, a company based in Southern Indiana.
The device, called the NSS-2 Bridge...
FDA nominee Gottlieb warns about opioid crisis
During his confirmation hearing, Dr. Scott Gottlieb, a physician and the nominee for head of the Food and Drug Administration (FDA), warned senators about...
- Advertisement -
